BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.48% | 20.75% | -0.73% | 19.96% | 1.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.48% | 20.75% | -0.73% | 19.96% | 1.59% |
| Cost of Revenue | -8.24% | 44.73% | 3.49% | 10.97% | 1.14% |
| Gross Profit | -1.62% | 13.05% | -2.19% | 23.48% | 1.77% |
| SG&A Expenses | 10.11% | 22.38% | 13.23% | 13.04% | 12.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 291.88% | -- | -- | -- | -- |
| Total Operating Expenses | 15.73% | 29.31% | 8.00% | 4.60% | 3.57% |
| Operating Income | -33.89% | 0.73% | -15.25% | 60.53% | -1.40% |
| Income Before Tax | -35.34% | 16.77% | -61.93% | 37.69% | 2.52% |
| Income Tax Expenses | -33.35% | 6.73% | -59.40% | 45.25% | -7.82% |
| Earnings from Continuing Operations | -35.86% | 19.88% | -62.59% | 35.67% | 5.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.86% | 19.88% | -62.59% | 35.67% | 5.61% |
| EBIT | -33.89% | 0.73% | -15.25% | 60.53% | -1.40% |
| EBITDA | -32.38% | 0.77% | -13.54% | 55.91% | -1.83% |
| EPS Basic | -36.00% | 19.78% | -62.58% | 35.62% | 5.64% |
| Normalized Basic EPS | -35.52% | 11.09% | -19.07% | 37.67% | 1.55% |
| EPS Diluted | -36.18% | 19.62% | -62.80% | 35.62% | 5.64% |
| Normalized Diluted EPS | -35.52% | 11.09% | -19.07% | 37.67% | 1.55% |
| Average Basic Shares Outstanding | 0.18% | 0.18% | 0.09% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.17% | 0.18% | 0.10% | 0.02% | 0.01% |
| Dividend Per Share | -- | 1.18% | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.73% | -- |